[An evidence-based terlipressin therapy for gastroesophageal variceal hemorrhage].
Zhonghua Gan Zang Bing Za Zhi
; 26(4): 245-248, 2018 Apr 20.
Article
in Zh
| MEDLINE
| ID: mdl-29996332
ABSTRACT
Gastroesophageal variceal bleeding is one of the major complications of cirrhosis and also the leading causes of death in patients with decompensated cirrhosis. Terlipressin is a triglycyl-lysine vasopressin, a synthetic vasopressin analogue that is mainly used for the treatment of acute variceal hemorrhage. This article aims to review the current status of treatment of gastroesophageal variceal bleeding with terlipressin from the perspective of evidence-based medicine.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Esophageal and Gastric Varices
/
Terlipressin
/
Gastrointestinal Hemorrhage
/
Liver Cirrhosis
Type of study:
Etiology_studies
Limits:
Humans
Language:
Zh
Journal:
Zhonghua Gan Zang Bing Za Zhi
Journal subject:
GASTROENTEROLOGIA
Year:
2018
Document type:
Article
Affiliation country:
China